Stem Cell Research (Jul 2020)

Generation of human induced pluripotent stem cell line (NIDCRi001-A) from a Muenke syndrome patient with an FGFR3 p.Pro250Arg mutation

  • Byron W.H. Mui,
  • Deepika Arora,
  • Barbara S. Mallon,
  • Ariel F. Martinez,
  • Janice S. Lee,
  • Maximilian Muenke,
  • Paul Kruszka,
  • Fahad K. Kidwai,
  • Pamela G. Robey

Journal volume & issue
Vol. 46
p. 101823

Abstract

Read online

Muenke syndrome is the leading genetic cause of craniosynostosis and results in a variety of disabling clinical phenotypes. To model the disease and study the pathogenic mechanisms, a human induced pluripotent stem cell (hiPSC) line was generated from a patient diagnosed with Muenke syndrome. Successful reprogramming was validated by morphological features, karyotyping, loss of reprogramming factors, expression of pluripotency markers, mutation analysis and teratoma formation.